Instrument Inactif

Communiqués Cell Source, Inc. Other OTC

Actions

CLCS

US15114L1044

Recherche biotechnologique et médicale

Communiqués

21/05	Cell Source Presented Its Breakthrough Developments for Mismatched Donor Stem Cell and Organ Transplants and Off-the-shelf CAR-T Cell Therapy at the LD Micro Invitational Conference in Los Angeles This Week	AQ
14/05	Cell Source, Inc. to Present at the LD Micro Invitational XVI	NE
14/05	Cell Source : Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)	PU
07/04	Cell Source : Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)	PU
08/12/22	Note 2 - Going Concern and Management Plans	AQ
02/12/22	Note 2 - Going Concern and Management Plans	AQ
02/11/22	Note 2 - Going Concern and Management Plans	AQ
21/07/22	CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
06/05/22	CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
15/04/22	CELL SOURCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
11/03/22	CELL SOURCE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (form 8-K)	AQ
15/11/21	Note 2 - Going Concern and Management Plans	AQ
12/08/21	Cell Source : Note 2 - Going Concern and Management Plans	AQ
17/05/21	Cell Source : Note 2 - Going Concern and Management Plans	AQ
15/04/21	CELL SOURCE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
02/04/21	CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
01/04/21	Cell Source : Darlene Soave Joins Cell Source's Board of Directors	PR
19/03/21	Cell Source : USPTO Issues New Patents for Cell Source's Veto Cell Technology	PR
13/11/20	Cell Source : Note 2 - Going Concern and Management Plans	AQ
14/08/20	Cell Source : Note 2 - Going Concern and Management Plans	AQ
15/05/20	Cell Source : Note 2 - Going Concern and Management Plans	AQ
30/03/20	CELL SOURCE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
30/11/-1	Cell Source Announces Closing of Private Placement and Hiring of Transfer Agent	AQ